{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:48:10Z","timestamp":1790750890229,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["938082"],"award-info":[{"award-number":["938082"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["NEI\/K08EY029765"],"award-info":[{"award-number":["NEI\/K08EY029765"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-023-09770-2","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T10:03:15Z","timestamp":1685527395000},"page":"7913-7922","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Orbital magnetic resonance imaging of giant cell arteritis with ocular manifestations: a systematic review and individual participant data meta-analysis"],"prefix":"10.1007","volume":"33","author":[{"given":"Konstanze V.","family":"Guggenberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Pavlou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quy","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishaan J.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi N.","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten A.","family":"Bley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh D.","family":"Curtin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Savatovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3127-6427","authenticated-orcid":false,"given":"Jae W.","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,31]]},"reference":[{"key":"9770_CR1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0002-9394(99)80192-5","volume":"125","author":"SS Hayreh","year":"1998","unstructured":"Hayreh SS, Podhajsky PA, Zimmerman B (1998) Ocular manifestations of giant cell arteritis. Am J Ophthalmol 125:509\u2013520","journal-title":"Am J Ophthalmol"},{"key":"9770_CR2","doi-asserted-by":"crossref","first-page":"192","DOI":"10.7326\/0003-4819-123-3-199508010-00006","volume":"123","author":"C Salvarani","year":"1995","unstructured":"Salvarani C, Gabriel SE, O\u2019Fallon WM, Hunder GG (1995) The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern. Ann Intern Med 123:192\u2013194","journal-title":"Ann Intern Med"},{"key":"9770_CR3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/03009742.2014.982701","volume":"44","author":"AK Chandran","year":"2015","unstructured":"Chandran AK, Udayakumar PD, Crowson CS, Warrington KJ, Matteson EL (2015) The incidence of giant cell arteritis in Olmsted County, Minnesota, over a 60-year period 1950\u20132009. Scand J Rheumatol 44:215\u2013218","journal-title":"Scand J Rheumatol"},{"key":"9770_CR4","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/art.1780261007","volume":"26","author":"CA Smith","year":"1983","unstructured":"Smith CA, Fidler WJ, Pinals RS (1983) The epidemiology of giant cell arteritis. Report of a ten-year study in Shelby County. Arthritis Rheum 26:1214\u20131219","journal-title":"Arthritis Rheum"},{"key":"9770_CR5","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/art.20227","volume":"51","author":"C Salvarani","year":"2004","unstructured":"Salvarani C, Crowson CS, O\u2019Fallon WM, Hunder GG, Gabriel SE (2004) Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period. Arthritis Rheum 51:264\u2013268","journal-title":"Arthritis Rheum"},{"key":"9770_CR6","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.3899\/jrheum.151033","volume":"43","author":"M Saleh","year":"2016","unstructured":"Saleh M, Turesson C, Englund M, Merkel PA, Mohammad AJ (2016) Visual complications in patients with biopsy-proven giant cell arteritis: a population-based study. J Rheumatol 43:1559\u20131565","journal-title":"J Rheumatol"},{"key":"9770_CR7","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1080\/03009742.2016.1266030","volume":"46","author":"J Ji","year":"2017","unstructured":"Ji J, Dimitrijevic I, Sundquist J, Sundquist K, Z\u00f6ller B (2017) Risk of ocular manifestations in patients with giant cell arteritis: a nationwide study in Sweden. Scand J Rheumatol 46:484\u2013489","journal-title":"Scand J Rheumatol"},{"key":"9770_CR8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00005792-200009000-00001","volume":"79","author":"MA Gonz\u00e1lez-Gay","year":"2000","unstructured":"Gonz\u00e1lez-Gay MA, Garc\u00eda-Porr\u00faa C, Llorca J et al (2000) Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients. Medicine (Baltimore) 79:283\u2013292","journal-title":"Medicine (Baltimore)"},{"key":"9770_CR9","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/112067210401400310","volume":"14","author":"F Costello","year":"2004","unstructured":"Costello F, Zimmerman MB, Podhajsky PA, Hayreh SS (2004) Role of thrombocytosis in diagnosis of giant cell arteritis and differentiation of arteritic from non-arteritic anterior ischemic optic neuropathy. Eur J Ophthalmol 14:245\u2013257","journal-title":"Eur J Ophthalmol"},{"key":"9770_CR10","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/eye.2016.19","volume":"30","author":"NM D\u2019Souza","year":"2016","unstructured":"D\u2019Souza NM, Morgan ML, Almarzouqi SJ, Lee AG (2016) Magnetic resonance imaging findings in giant cell arteritis. Eye (Lond) 30:758\u2013762","journal-title":"Eye (Lond)"},{"key":"9770_CR11","volume":"148","author":"CT Berger","year":"2018","unstructured":"Berger CT, Sommer G, Aschwanden M, Staub D, Rottenburger C, Daikeler T (2018) The clinical benefit of imaging in the diagnosis and treatment of giant cell arteritis. Swiss Med Wkly 148:w14661","journal-title":"Swiss Med Wkly"},{"key":"9770_CR12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2214\/ajr.184.1.01840283","volume":"184","author":"TA Bley","year":"2005","unstructured":"Bley TA, Wieben O, Uhl M, Thiel J, Schmidt D, Langer M (2005) High-resolution MRI in giant cell arteritis: imaging of the wall of the superficial temporal artery. AJR Am J Roentgenol 184:283\u2013287","journal-title":"AJR Am J Roentgenol"},{"key":"9770_CR13","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1097\/RLI.0000000000000595","volume":"54","author":"N Mohammed-Brahim","year":"2019","unstructured":"Mohammed-Brahim N, Clavel G, Charbonneau F et al (2019) Three Tesla 3D high-resolution vessel wall MRI of the orbit may differentiate arteritic from nonarteritic anterior ischemic optic neuropathy. Invest Radiol 54:712\u2013718","journal-title":"Invest Radiol"},{"key":"9770_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-022-09256-7","author":"KV Guggenberger","year":"2022","unstructured":"Guggenberger KV, Vogt ML, Song JW et al (2022) Intraorbital findings in giant cell arteritis on black blood MRI. Eur Radiol. https:\/\/doi.org\/10.1007\/s00330-022-09256-7","journal-title":"Eur Radiol"},{"key":"9770_CR15","doi-asserted-by":"crossref","first-page":"e236","DOI":"10.1016\/j.jcjo.2018.02.013","volume":"53","author":"S AlShaker","year":"2018","unstructured":"AlShaker S, Shemesh AA, Margolin E (2018) Enhancement of optic nerve sheath in AAION: a case of visual recovery in fulminant GCA. Can J Ophthalmol 53:e236\u2013e239","journal-title":"Can J Ophthalmol"},{"key":"9770_CR16","first-page":"235","volume":"19","author":"AG Lee","year":"1999","unstructured":"Lee AG, Eggenberger ER, Kaufman DI, Manrique C (1999) Optic nerve enhancement on magnetic resonance imaging in arteritic ischemic optic neuropathy. J Neuroophthalmol 19:235\u2013237","journal-title":"J Neuroophthalmol"},{"key":"9770_CR17","volume":"8","author":"A Nambiema","year":"2021","unstructured":"Nambiema A, Sembajwe G, Lam J et al (2021) A protocol for the use of case reports\/studies and case series in systematic reviews for clinical toxicology. Front Med (Lausanne) 8:708380","journal-title":"Front Med (Lausanne)"},{"key":"9770_CR18","unstructured":"Tierney JF SL, Clarke M (2022) Chapter 26: individual partcipant data. In: Higgins JPT TJ, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors), (ed) Cochrane Handbook for Systematic Reviews of Interventions version 63. Cochrane"},{"key":"9770_CR19","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jclinepi.2013.08.003","volume":"67","author":"JJ Gagnier","year":"2014","unstructured":"Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D (2014) The CARE guidelines: consensus-based clinical case report guideline development. J Clin Epidemiol 67:46\u201351","journal-title":"J Clin Epidemiol"},{"key":"9770_CR20","unstructured":"Institute JB (2017) Checklist for Case Reports. The Joana Briggs Institute, www.joannabriggs.org. Available via https:\/\/jbi.global\/sites\/default\/files\/2019-05\/JBI_Critical_Appraisal-Checklist_for_Case_Reports2017_0.pdf. Accessed November 10, 2022 2022"},{"key":"9770_CR21","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jcrs.2004.01.014","volume":"30","author":"JT Holladay","year":"2004","unstructured":"Holladay JT (2004) Visual acuity measurements. J Cataract Refract Surg 30:287\u2013290","journal-title":"J Cataract Refract Surg"},{"key":"9770_CR22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0896-1549(03)00013-0","volume":"16","author":"C Kniestedt","year":"2003","unstructured":"Kniestedt C, Stamper RL (2003) Visual acuity and its measurement. Ophthalmol Clin North Am 16:155\u2013170","journal-title":"Ophthalmol Clin North Am"},{"key":"9770_CR23","doi-asserted-by":"crossref","unstructured":"Virgili G, Acosta R, Bentley SA, Giacomelli G, Allcock C, Evans JR (2018) Reading aids for adults with low vision. Cochrane Database Syst Rev 4:Cd003303","DOI":"10.1002\/14651858.CD003303.pub4"},{"key":"9770_CR24","volume":"87","author":"DD Kim","year":"2016","unstructured":"Kim DD, Budhram A, Pelz D, MacDonald M (2016) Teaching neuroimages: orbital infarction syndrome from giant cell arteritis. Neurology 87:e269","journal-title":"Neurology"},{"key":"9770_CR25","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s004170100310","volume":"239","author":"AG Lee","year":"2001","unstructured":"Lee AG, Tang RA, Feldon SE et al (2001) Orbital presentations of giant cell arteritis. Graefes Arch Clin Exp Ophthalmol 239:509\u2013513","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"9770_CR26","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/WNO.0000000000000860","volume":"41","author":"SM Gospe 3rd","year":"2021","unstructured":"Gospe SM 3rd, Amrhein TJ, Malinzak MD, Bhatti MT, Mettu P, El-Dairi MA (2021) Magnetic resonance imaging abnormalities of the optic nerve sheath and intracranial internal carotid artery in giant cell arteritis. J Neuroophthalmol 41:54\u201359","journal-title":"J Neuroophthalmol"},{"key":"9770_CR27","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/WNO.0b013e3182915b77","volume":"33","author":"KC Liu","year":"2013","unstructured":"Liu KC, Chesnutt DA (2013) Perineural optic nerve enhancement on magnetic resonance imaging in giant cell arteritis. J Neuroophthalmol 33:279\u2013281","journal-title":"J Neuroophthalmol"},{"key":"9770_CR28","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1097\/WNO.0000000000000951","volume":"41","author":"S Emami","year":"2021","unstructured":"Emami S, Howarth D, Margolin E (2021) Giant cell arteritis presenting as bilateral optic perineuritis in an african man. J Neuroophthalmol 41:e149\u2013e152","journal-title":"J Neuroophthalmol"},{"key":"9770_CR29","doi-asserted-by":"crossref","first-page":"851","DOI":"10.5692\/clinicalneurol.cn-001643","volume":"61","author":"T Tashiro","year":"2021","unstructured":"Tashiro T, Tsujimoto A, Nakamura N (2021) Ischemic optic neuropathy despite pulse methylprednisolone therapy in a giant cell arteritis patient with perineural optic nerve enhancement. Rinsho Shinkeigaku 61:851\u2013855","journal-title":"Rinsho Shinkeigaku"},{"key":"9770_CR30","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/rheumatology\/kep011","volume":"48","author":"J Geiger","year":"2009","unstructured":"Geiger J, Ness T, Uhl M et al (2009) Involvement of the ophthalmic artery in giant cell arteritis visualized by 3T MRI. Rheumatology (Oxford) 48:537\u2013541","journal-title":"Rheumatology (Oxford)"},{"key":"9770_CR31","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/WNO.0000000000000529","volume":"37","author":"M Ross","year":"2017","unstructured":"Ross M, Bursztyn L, Superstein R, Gans M (2017) Multiple cranial nerve palsies in giant cell arteritis. J Neuroophthalmol 37:398\u2013400","journal-title":"J Neuroophthalmol"},{"key":"9770_CR32","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s12886-018-0994-9","volume":"18","author":"AM Albarrak","year":"2018","unstructured":"Albarrak AM, Mohammad Y, Hussain S, Husain S, Muayqil T (2018) Simultaneous bilateral posterior ischemic optic neuropathy secondary to giant cell arteritis: a case presentation and review of the literature. BMC Ophthalmol 18:317","journal-title":"BMC Ophthalmol"},{"key":"9770_CR33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000329885","volume":"66","author":"D Biotti","year":"2011","unstructured":"Biotti D, Savatovski J, Bidot S et al (2011) Diffusion MR imaging of the optic nerve in a patient with giant-cell arteritis and vertebral artery vasculitis. Eur Neurol 66:83\u201384","journal-title":"Eur Neurol"},{"key":"9770_CR34","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/art.21089","volume":"53","author":"C Garcia-Porrua","year":"2005","unstructured":"Garcia-Porrua C, Santamarina R, Armesto V, Gonzalez-Gay MA (2005) Magnetic resonance imaging in optic neuritis due to giant cell arteritis. Arthritis Rheum 53:313\u2013314","journal-title":"Arthritis Rheum"},{"key":"9770_CR35","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.ophtha.2018.04.032","volume":"125","author":"A Heraud","year":"2018","unstructured":"Heraud A, Zmuda M, Lecler A (2018) Lacrimal gland ischemia due to giant cell arteritis. Ophthalmology 125:1233","journal-title":"Ophthalmology"},{"key":"9770_CR36","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/art.11372","volume":"49","author":"C Garcia-Porrua","year":"2003","unstructured":"Garcia-Porrua C, Pego-Reigosa R, Armesto V, Gonzalez-Gay MA (2003) Neovascularization around the optic nerve in giant cell arteritis. Arthritis Rheum 49:737\u2013738","journal-title":"Arthritis Rheum"},{"key":"9770_CR37","doi-asserted-by":"crossref","unstructured":"Kornberg MD, Ratchford JN, Subramaniam RM, Probasco JC (2015) Giant cell arteritis mimicking infiltrative leptomeningeal disease of the optic nerves. BMJ Case Rep 2015","DOI":"10.1136\/bcr-2014-209160"},{"key":"9770_CR38","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jcjo.2020.04.002","volume":"55","author":"L Donaldson","year":"2020","unstructured":"Donaldson L, Nanji K, Rebello R, Khalidi NA, Rodriguez AR (2020) Involvement of the intracranial circulation in giant cell arteritis. Can J Ophthalmol 55:391\u2013400","journal-title":"Can J Ophthalmol"},{"key":"9770_CR39","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00062-014-0346-y","volume":"25","author":"M Hittinger","year":"2015","unstructured":"Hittinger M, Berlis A, Pfadenhauer K (2015) Inflammatory Pseudo-tumour Orbitae (PTO): an atypical manifestation of giant cell arteritis (GCA). Clin Neuroradiol 25:411\u2013414","journal-title":"Clin Neuroradiol"},{"key":"9770_CR40","first-page":"625","volume":"30","author":"KE Morgenstern","year":"2003","unstructured":"Morgenstern KE, Ellis BD, Schochet SS, Linberg JV (2003) Bilateral optic nerve sheath enhancement from giant cell arteritis. J Rheumatol 30:625\u2013627","journal-title":"J Rheumatol"},{"key":"9770_CR41","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1001\/archneur.57.1.119","volume":"57","author":"E Joelson","year":"2000","unstructured":"Joelson E, Ruthrauff B, Ali F, Lindeman N, Sharp FR (2000) Multifocal dural enhancement associated with temporal arteritis. Arch Neurol 57:119\u2013122","journal-title":"Arch Neurol"},{"key":"9770_CR42","first-page":"367","volume":"13","author":"S Nassani","year":"1995","unstructured":"Nassani S, Cocito L, Arcuri T, Favale E (1995) Orbital pseudotumor as a presenting sign of temporal arteritis. Clin Exp Rheumatol 13:367\u2013369","journal-title":"Clin Exp Rheumatol"},{"key":"9770_CR43","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3988\/jcn.2019.15.3.386","volume":"15","author":"JH Choi","year":"2019","unstructured":"Choi JH, Shin JH, Jung JH (2019) Arteritic anterior ischemic optic neuropathy associated with giant-cell arteritis in Korean patients: a retrospective single-center analysis and review of the literature. J Clin Neurol 15:386\u2013392","journal-title":"J Clin Neurol"},{"key":"9770_CR44","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4103\/ijo.IJO_1681_20","volume":"69","author":"SS Hayreh","year":"2021","unstructured":"Hayreh SS (2021) Giant cell arteritis: its ophthalmic manifestations. Indian J Ophthalmol 69:227\u2013235","journal-title":"Indian J Ophthalmol"},{"key":"9770_CR45","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/bjo.87.6.777","volume":"87","author":"HE Killer","year":"2003","unstructured":"Killer HE, Laeng HR, Flammer J, Groscurth P (2003) Architecture of arachnoid trabeculae, pillars, and septa in the subarachnoid space of the human optic nerve: anatomy and clinical considerations. Br J Ophthalmol 87:777\u2013781","journal-title":"Br J Ophthalmol"},{"key":"9770_CR46","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0950-3579(05)80064-0","volume":"5","author":"SS Hayreh","year":"1991","unstructured":"Hayreh SS (1991) Ophthalmic features of giant cell arteritis. Baillieres Clin Rheumatol 5:431\u2013459","journal-title":"Baillieres Clin Rheumatol"},{"key":"9770_CR47","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1007\/s00330-021-08413-8","volume":"32","author":"K-J Zhang","year":"2022","unstructured":"Zhang K-J, Li M-X, Zhang P, Qin H-Q, Guo Z-N, Yang Y (2022) Validity of high resolution magnetic resonance imaging in detecting giant cell arteritis: a meta-analysis. Eur Radiol 32:3541\u20133552","journal-title":"Eur Radiol"},{"key":"9770_CR48","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2017-000612","volume":"4","author":"C Duftner","year":"2018","unstructured":"Duftner C, Dejaco C, Sepriano A, Falzon L, Schmidt WA, Ramiro S (2018) Imaging in diagnosis, outcome prediction and monitoring of large vessel vasculitis: a systematic literature review and meta-analysis informing the EULAR recommendations. RMD Open 4:e000612","journal-title":"RMD Open"},{"key":"9770_CR49","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/annrheumdis-2017-212649","volume":"77","author":"C Dejaco","year":"2018","unstructured":"Dejaco C, Ramiro S, Duftner C et al (2018) EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis 77:636\u2013643","journal-title":"Ann Rheum Dis"},{"key":"9770_CR50","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1136\/bjophthalmol-2017-310718","volume":"102","author":"ED Gaier","year":"2018","unstructured":"Gaier ED, Gilbert AL, Cestari DM, Miller JB (2018) Optical coherence tomographic angiography identifies peripapillary microvascular dilation and focal non-perfusion in giant cell arteritis. Br J Ophthalmol 102:1141\u20131146","journal-title":"Br J Ophthalmol"},{"key":"9770_CR51","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/01658107.2016.1275703","volume":"41","author":"JJ Chen","year":"2017","unstructured":"Chen JJ, AbouChehade JE, Iezzi R Jr, Leavitt JA, Kardon RH (2017) Optical coherence angiographic demonstration of retinal changes from chronic optic neuropathies. Neuroophthalmology 41:76\u201383","journal-title":"Neuroophthalmology"},{"key":"9770_CR52","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.semarthrit.2016.11.002","volume":"46","author":"K Tuckwell","year":"2017","unstructured":"Tuckwell K, Collinson N, Dimonaco S et al (2017) Newly diagnosed vs. relapsing giant cell arteritis: baseline data from the GiACTA trial. Semin Arthritis Rheum 46:657\u2013664","journal-title":"Semin Arthritis Rheum"},{"key":"9770_CR53","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s13075-017-1479-6","volume":"19","author":"LK Brekke","year":"2017","unstructured":"Brekke LK, Diamantopoulos AP, Fevang BT, A\u03b2mus J, Esper\u00f8 E, Gjesdal CG (2017) Incidence of giant cell arteritis in Western Norway 1972\u20132012: a retrospective cohort study. Arthritis Res Ther 19:278","journal-title":"Arthritis Res Ther"},{"key":"9770_CR54","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/rheumatology\/38.12.1208","volume":"38","author":"V Petursdottir","year":"1999","unstructured":"Petursdottir V, Johansson H, Nordborg E, Nordborg C (1999) The epidemiology of biopsy-positive giant cell arteritis: special reference to cyclic fluctuations. Rheumatology (Oxford) 38:1208\u20131212","journal-title":"Rheumatology (Oxford)"},{"key":"9770_CR55","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/00000478-199206000-00014","volume":"16","author":"MR Ashton-Key","year":"1992","unstructured":"Ashton-Key MR, Gallagher PJ (1992) False-negative temporal artery biopsy. Am J Surg Pathol 16:634\u2013635","journal-title":"Am J Surg Pathol"},{"key":"9770_CR56","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000050778","volume":"46","author":"JM L\u00f3pez","year":"2001","unstructured":"L\u00f3pez JM, Nazabal ER, Mu\u00f1iz AM, Rey del Corral P (2001) Detection of posterior ischemic optic neuropathy due to giant cell arteritis with magnetic resonance imaging. Eur Neurol 46:109\u2013110","journal-title":"Eur Neurol"},{"key":"9770_CR57","first-page":"1149","volume":"38","author":"AJ Botella-Ortiz","year":"2004","unstructured":"Botella-Ortiz AJ, Pampliega-P\u00e9rez A, Mart\u00edn-Estefan\u00eda C, Alfaro-S\u00e1ez A, Concepci\u00f3n L, Teruel A (2004) The value of orbit magnetic resonance imaging in the diagnosis of blindness caused by giant cell arteritis. Rev Neurol 38:1149\u20131152","journal-title":"Rev Neurol"},{"key":"9770_CR58","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/practneurol-2014-000834","volume":"14","author":"JR Mitchell","year":"2014","unstructured":"Mitchell JR, Krashin-Bichler I, Rosenblum M, Diamond EL, Dinkin MJ (2014) Giant cell arteritis presenting with bilateral orbital inflammatory disease and enhancing superficial temporal arteries. Pract Neurol 14:446\u2013447","journal-title":"Pract Neurol"},{"key":"9770_CR59","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.2147\/OPTH.S82898","volume":"9","author":"T Attaseth","year":"2015","unstructured":"Attaseth T, Vanikieti K, Poonyathalang A, Preechawat P, Jindahra P, Wattanatranon D (2015) Anterior ischemic optic neuropathy due to biopsy-proven giant cell arteritis in Thai patients. Clin Ophthalmol 9:1071\u20131075","journal-title":"Clin Ophthalmol"},{"key":"9770_CR60","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1016\/j.jcjo.2015.07.007","volume":"50","author":"JJ Chen","year":"2015","unstructured":"Chen JJ, Kardon RH, Daley TJ, Longmuir RA (2015) Enhancement of the optic nerve sheath and temporal arteries from giant cell arteritis. Can J Ophthalmol 50:e96-97","journal-title":"Can J Ophthalmol"},{"key":"9770_CR61","volume":"12","author":"KA Mears","year":"2020","unstructured":"Mears KA, Feinsilber D (2020) High-sensitivity C-reactive protein and magnetic resonance imaging in occult giant cell arteritis. Cureus 12:e9530","journal-title":"Cureus"},{"key":"9770_CR62","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.rxeng.2020.02.003","volume":"62","author":"E Serrano Alcal\u00e1","year":"2020","unstructured":"Serrano Alcal\u00e1 E, Griv\u00e9 Isern E, D\u00edez Borras L, Salaya D\u00edaz JT (2020) Orbital Magnetic Resonance Imaging to unmask giant cell arteritis. Radiologia (Engl Ed) 62:160\u2013163","journal-title":"Radiologia (Engl Ed)"},{"key":"9770_CR63","doi-asserted-by":"publisher","DOI":"10.1097\/wno.0000000000001415","author":"Panneerselvam S, Raviskanthan S, Mo","year":"2021","unstructured":"Panneerselvam S, Raviskanthan S, Mortensen PW, Lee AG (2021) giant cell arteritis presenting as central retinal artery occlusion and optic perineuritis: the importance of contrast MRI of the orbit. J Neuroophthalmol. https:\/\/doi.org\/10.1097\/wno.0000000000001415","journal-title":"J Neuroophthalmol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-023-09770-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-023-09770-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-023-09770-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T17:06:36Z","timestamp":1698167196000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-023-09770-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,31]]},"references-count":63,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["9770"],"URL":"https:\/\/doi.org\/10.1007\/s00330-023-09770-2","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,31]]},"assertion":[{"value":"16 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The scientific guarantor of this publication is Jae W. Song, MD, MS.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare relationships with the following companies: Julien Savatovsky, MD reports fees to prepare and give lectures by Canon, Novartis; Boards: Bayer, Biogen; Travel expenses: Bayer. Stocks: Chipiron and Guerbet.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Quy Cao, PhD, kindly provided statistical advice for this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was not required for this study because it is a literature-based systematic review.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was not required because it is a literature-based systematic review of the literature.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"value":"Systematic Review and Individual Participant Data Meta-Analysis of the Literature. The PRIMSA guidelines were followed. This study was registered with PROSPER (Clinical trial registration no. CRD42021254494).","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}